Alebund Pharmaceuticals (Jiangsu) Limited (SEHK: 9637)
Health Care · Pharmaceuticals · CN
HK$33.48
-6.69% today · -27.2% 1Y
Alebund Pharmaceuticals (Jiangsu) Limited (SEHK: 9637) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.45B.
Over the last twelve months the share price has lost 27.2%, trading between 22.72 and 46.82.
9637 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.45B
- Revenue (TTM)
- $4.37M
- P/E
- —
- EPS
- -3.07
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- HK$46.82
- 52-week low
- HK$22.72
- Avg volume (3M)
- —
- Shares outstanding
- 339.85M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,226.58 | -0.57% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $271.58 | -0.57% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.68 | -1.77% |
| Roche Holding AGSWX: ROP | $371.62B | CHF369.70 | -1.10% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.92 | -1.47% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.35 | -0.77% |
Figures last refreshed Aug 18, 2026.